作者
Maria J. G. T. Vehreschild,Lena M. Biehl,Aaron Dane,Marlieke E.A. de Kraker,Leen Timbermont,C. Henri van Werkhoven
摘要
Journal Article An obituary on DAV-132—authors' viewpoint on the current limits of pivotal trials in clinical microbiome research Get access Maria J G T Vehreschild, Maria J G T Vehreschild Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany Corresponding author. E-mail: maria.vehreschild@kgu.de Search for other works by this author on: Oxford Academic PubMed Google Scholar Lena M Biehl, Lena M Biehl Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany Search for other works by this author on: Oxford Academic PubMed Google Scholar Aaron Dane, Aaron Dane Danestat Consulting Limited, Macclesfield, UK Search for other works by this author on: Oxford Academic PubMed Google Scholar Marlieke E A de Kraker, Marlieke E A de Kraker Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland https://orcid.org/0000-0003-0903-8614 Search for other works by this author on: Oxford Academic PubMed Google Scholar Leen Timbermont, Leen Timbermont Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium Search for other works by this author on: Oxford Academic PubMed Google Scholar C Henri van Werkhoven C Henri van Werkhoven Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands Search for other works by this author on: Oxford Academic PubMed Google Scholar Journal of Antimicrobial Chemotherapy, Volume 78, Issue 6, June 2023, Pages 1551–1553, https://doi.org/10.1093/jac/dkad123 Published: 26 April 2023